OncoHost

Our CEO, Dr. Ofer Sharon, will be presenting at the upcoming #LSIEurope24 conference in Portugal this month! We’re looking forward to connecting with industry leaders, innovators, and attendees at this fantastic event. Are you attending? Let’s connect ahead of time—reach out to schedule a meeting: hello@oncohost.com #conference #biotech #innovation #networking #healthtech

Oncologists treating #mNSCLC: the PROphetNSCLC™ report has a new look! Order the test for eligible patients to see it in action; results are available within 8 days from sample receipt at our CLIA lab. You can also review sample reports here: https://bit.ly/47uMwnh #LungCancer #Oncology #PrecisionMedicine

Exciting News! 🤩 We're thrilled to announce our acceptance to present a poster at #ESMO2024! We'll be showcasing new research on our PROphet® platform, demonstrating its potential to predict clinical outcomes in #renalcellcarcinoma (RCC). In collaboration with Dana-Farber Cancer Institute, our findings reveal that #RCC patients identified as PROphet-POSITIVE showed significantly improved survival outcomes, highlighting the platform’s versatility across multiple #cancer types. Join us in Barcelona as we continue to push the boundaries of precision medicine! Details: 📅 Sunday, 15 September 2024 📍 ESMO Congress 2024, Barcelona 🎓 Presenter: Dr. Eddy Saad, MD, MSc, Dana-Farber Read more: https://bit.ly/3TnC1fL #PrecisionMedicine #CancerResearch

Prof. Jarushka Naidoo will be presenting research on using plasma proteomics to predict immunotherapy and chemotherapy toxicity in #NSCLC patients at #WCLC2024 on Tuesday, September 10th at 11:15am PDT. Don't miss this presentation in Room 30DE on leveraging proteomics as #biomarkers. #LungCancer #Proteomics #Immunotherapy #Chemotherapy

We're excited to be at the World Conference on Lung Cancer #WCLC2024 this week! Yesterday, our team had a great poster presentation on our latest research findings and our booth has been busy as well. We can't wait for Dr. Gandara's poster presentation later today at 12PM PDT titled "A Plasma Proteomics-Based Model for Clinical Benefit Prediction in Small Cell Lung Cancer Patients Receiving Immunotherapy." Are you attending WCLC? Stop by our booth #2500 to meet our team and find out what PROphet® is and how it's impacting #immunotherapy treatment decisions.

Dr. Itamar Sela will delve into mechanisms of #immunotherapy resistance in metastatic #NSCLC, offering valuable insights into the biological processes underlying resistance to immunotherapy during a poster presentation at #WCLC2024 on Sunday, September 8th. Find him at Poster #2495 or stop by our booth #2500!

🚨 Industry News 🚨 The FDA has approved a powerful new combination therapy for the first-line treatment of adults with locally advanced or #metastatic non–small cell lung cancer with #EGFR mutations. The approved combo: Lazertinib (Lazcluze), marking its first FDA approval, and Amivantamab-vmjw (Rybrevant), which was first approved in 2021. This approval, based on the phase 3 MARIPOSA trial, is a significant milestone in the treatment of #NSCLC, offering patients a potential new first-line standard of care with substantial clinical benefits over osimertinib. The trial showed a 30% reduction in the risk of disease progression or death with this combination. As NSCLC treatment evolves, this new option highlights the ongoing advancements in #personalizedmedicine, bringing renewed hope to those facing this challenging diagnosis. https://lnkd.in/dbMKc8bM #LungCancer #PrecisionMedicine #LCSM

Our team is attending the ESMO Congress 2024 in Barcelona! 🚀 Join us as leading experts, researchers, and oncologists gather to share the latest breakthroughs in #oncology, with a special focus on personalized #cancertreatment. This event is a hub of collaboration and innovation. Stay tuned for more exciting updates from ESMO Congress—we have some great news to share in the coming days! To connect with our team during the event, reach out to us at hello@oncohost.com. See you there! #ESMO2024 #OncologyResearch #MedicalConference #PrecisionOncology Adam Dicker Chris Dingman Nava Almog Yehonatan Elon Shani Raveh Shoval Eyal Jacob

Happy Labor Day to our US-based team and partners! We hope your weekend has been filled with celebration, relaxation, and a shared sense of gratitude 🌞 #laborday #LDW #labordayweekend #happylaborday

Today, OncoHost Israel will pause operations to stand in solidarity with the hostages and their families. This is a time for reflection, unity, and strength. Our unwavering commitment to improving patient care remains steadfast during these challenging moments. Together, we hope and pray for their safe return. #BringThemHomeNow